nibirucms.ru


Overview

Oric Pharmaceuticals Stock Forecast

Oric Pharmaceuticals Stock Forecast

Growth Estimates ; Current Qtr. %, -- ; Next Qtr. %, -- ; Current Year, %, -- ; Next Year, %, Oric Pharmaceuticals Stock Buy Hold or Sell Recommendation · Stocks. USA. Given the investment horizon of 90 days and your above-average risk tolerance, our. Oric Pharmaceuticals Inc ORIC:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/06/24 · 52 Week Low Stock price target for Oric Pharmaceuticals Inc ORIC are on downside and on upside. Stock price target for Oric Pharmaceuticals Inc ORIC are on. ORIC Pharmaceuticals, Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for ORIC Pharmaceuticals, Inc. Stock | ORIC | USP ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the. View ORIC Pharmaceuticals Inc ORIC stock quote prices, financial information, real-time forecasts, and company news from CNN. ORIC Oric Pharmaceuticals · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss. The 6 analysts with month price forecasts for ORIC stock have an average target of , with a low estimate of 14 and a high estimate of The average. Growth Estimates ; Current Qtr. %, -- ; Next Qtr. %, -- ; Current Year, %, -- ; Next Year, %, Oric Pharmaceuticals Stock Buy Hold or Sell Recommendation · Stocks. USA. Given the investment horizon of 90 days and your above-average risk tolerance, our. Oric Pharmaceuticals Inc ORIC:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/06/24 · 52 Week Low Stock price target for Oric Pharmaceuticals Inc ORIC are on downside and on upside. Stock price target for Oric Pharmaceuticals Inc ORIC are on. ORIC Pharmaceuticals, Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for ORIC Pharmaceuticals, Inc. Stock | ORIC | USP ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the. View ORIC Pharmaceuticals Inc ORIC stock quote prices, financial information, real-time forecasts, and company news from CNN. ORIC Oric Pharmaceuticals · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Loss. The 6 analysts with month price forecasts for ORIC stock have an average target of , with a low estimate of 14 and a high estimate of The average.

Oric Pharmaceuticals started at overweight with $40 stock price target at J.P. Morgan. May. 19, at a.m. ET by Tomi Kilgore. No Headlines Available.

The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC, an orally. Yes ☐ No ☒ As of May 4, , the registrant had 39,, shares of common stock, $ par value per share, outstanding However, our forecast of. (NASDAQ: ORIC) Oric Pharmaceuticals currently has 70,, outstanding shares. With Oric Pharmaceuticals stock trading at $ per share, the total value of. ORIC Pharmaceuticals Inc ORIC ; - , - , , Stock Price Target. High, $ Low, $ Average, $ Current Price, $ ORIC will report FY earnings on 03/25/ Yearly Estimates. Current Oric Pharmaceuticals forecasts and price targets in August ; Buy, % (14) ; Hold, % (1) ; Sell, 0 % (0) ; 12M Price Target. ; Last Price. With an AI score of 48, the ORIC stock forecast suggests stability. What is the ORIC price prediction for ? To predict the price for ORIC in , we can. The average one-year price target for ORIC Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. ORIC Pharmaceuticals Stock Forecast, ORIC stock price prediction. Price target in 14 days: USD. The best long-term & short-term ORIC Pharmaceuticals. ORIC's current price target is $ Learn why top analysts are making this stock forecast for ORIC Pharmaceuticals at MarketBeat. The Oric Pharmaceuticals stock forecast for tomorrow is $ , which would represent a % loss compared to the current price. In the next week, the price. Analyst Price Targets​​ Based on analysts offering 12 month price targets for ORIC in the last 3 months. The average price target is $ with a high estimate. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a. Oric Pharmaceuticals (ORIC) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Out of 6 analysts, 2 (%) are recommending ORIC as a Strong Buy, 4 (%) are recommending ORIC as a Buy, 0 (0%) are recommending ORIC as a Hold, 0 (0%). Oric Pharmaceuticals Inc stock price live, this page displays NASDAQ ORIC stock exchange data. View the ORIC premarket stock price ahead of the market session. Yes, Indians can invest in the Oric Pharmaceuticals (ORIC) from India. With INDmoney, you can buy Oric Pharmaceuticals at 0 brokerage. The step-by-step process. ORIC - ORIC Pharmaceuticals, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). According to analysts, ORIC price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. ORIC Pharmaceuticals Price prediction day by day ; July 02, Tuesday, , , ; July 03, Wednesday, , ,

1 2 3 4 5

Copyright 2015-2024 Privice Policy Contacts